Global Cardiac Biomarkers Testing Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

Section 1: Introduction

1.1. Market Report description
1.2. Market Key benefits for stakeholders
1.3. Key market segments
1.4. market Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Section 2: Market EXECUTIVE SUMMARY

2.1. Key findings

2.1.1. Top impacting factors
2.1.2. Top investment pockets

2.2. CXO perspective

Section 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Biomarker diagnosis vs. conventional diagnosis
3.3. Assessment of key advantages and buying criteria for diagnostic biomarkers

3.3.1. Early diagnosis
3.3.2. Tissue specific diagnosis
3.3.3. Reduce clinical trials
3.3.4. Consistent output

3.4. Key trends impacting the Cardiac biomarker testing market

3.4.1. Development of high sensitive biomarkers for risk stratification
3.4.2. Technological advancements in the cardiac biomarkers: Serum based biomarkers
3.4.3. Increasing demand for point of care cardiac diagnostics

3.5. Parent Market Overview
3.6. Key Forces Shaping Cardiac biomarker testing market

3.6.1. High bargaining power of suppliers
3.6.2. Low bargaining power of buyers
3.6.3. Low threat of new entrants
3.6.4. Low threat of substitutes
3.6.5. High intensity of rivalry

3.7. Value chain analysis
3.8. Pricing Analysis

3.8.1. Pricing Analysis, By Region, 2018 & 2025

3.9. Market evolution/Industry roadmap
3.10. Government regulations
3.11. Reimbursement issues
3.12. Patent Analysis

3.12.1. By Region (2016-2018)
3.12.2. By Applicant

3.13. Market share analysis
3.14. Case Studies

3.14.1. Case Study

3.15. Market dynamics

3.15.1. Drivers

3.15.1.1. Increasing prevalence of cardiovascular diseases
3.15.1.2. Cost effective
3.15.1.3. Non-invasive
3.15.1.4. Accuracy prediction
3.15.1.5. Technological advancements using cardiac biomarkers combinations
3.15.1.6. Increasing point of care (POC) testing

3.15.2. Restraints

3.15.2.1. Government Regulation
3.15.2.2. Conformation in result
3.15.2.3. Complex process

3.15.3. Opportunities

3.15.3.1. Personalized medicine
3.15.3.2. Point of care (POCT) testing using cardiac biomarkers

Section 4: CARDIAC BIOMARKER TESTING MARKET, BY TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Creatine kinase (CK-MB)

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. Troponins

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

4.4. Myoglobin

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

4.5. Natriuretic peptides (BNP and NT-proBNP)

4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country

4.6. Ischemia modified albumin

4.6.1. Key market trends and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country

4.7. Others

4.7.1. Key market trends and opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country

Section 5: CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Myocardial infarction

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Congestive heart failure

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Acute coronary syndrome

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

5.5. Atherosclerosis

5.5.1. Market size and forecast
5.5.2. Market analysis, by country

5.6. Other applications

5.6.1. Market size and forecast
5.6.2. Market analysis, by country

Section 6: CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING

6.1. Overview

6.1.1. Market size and forecast

6.2. Point of care testing

6.2.1. Market size and forecast
6.2.2. Market analysis, by country

6.3. Laboratory testing

6.3.1. Market size and forecast
6.3.2. Market analysis, by country

Section 7: CARDIAC BIOMARKER TESTING MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends and opportunities
7.2.2. North America market size and forecast, by type
7.2.3. North America market size and forecast, by application
7.2.4. North America market size and forecast, by location of testing
7.2.5. North America market size and forecast, by country

7.2.5.1. U.S.

7.2.5.1.1. U.S. market size and forecast, by type
7.2.5.1.2. U.S. market size and forecast, by application
7.2.5.1.3. U.S. market size and forecast, by location of testing

7.2.5.2. Canada

7.2.5.2.1. Canada market size and forecast, by type
7.2.5.2.2. Canada market size and forecast, by application
7.2.5.2.3. Canada market size and forecast, by location of testing

7.2.5.3. Mexico

7.2.5.3.1. Mexico market size and forecast, by type
7.2.5.3.2. Mexico market size and forecast, by application
7.2.5.3.3. Mexico market size and forecast, by location of testing

7.3. Europe

7.3.1. Key market trends and opportunities
7.3.2. Europe market size and forecast, by type
7.3.3. Europe market size and forecast, by application
7.3.4. Europe market size and forecast, by location of testing
7.3.5. Europe market size and forecast, by country

7.3.5.1. UK

7.3.5.1.1. UK market size and forecast, by type
7.3.5.1.2. UK market size and forecast, by application
7.3.5.1.3. UK market size and forecast, by location of testing

7.3.5.2. France

7.3.5.2.1. France market size and forecast, by type
7.3.5.2.2. France market size and forecast, by application
7.3.5.2.3. France market size and forecast, by location of testing

7.3.5.3. Germany

7.3.5.3.1. Germany market size and forecast, by type
7.3.5.3.2. Germany market size and forecast, by application
7.3.5.3.3. Germany market size and forecast, by location of testing

7.3.5.4. Rest of Europe

7.3.5.4.1. Rest of Europe market size and forecast, by type
7.3.5.4.2. Rest of Europe market size and forecast, by application
7.3.5.4.3. Rest of Europe market size and forecast, by location of testing

7.4. Asia-Pacific

7.4.1. Key market trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by type
7.4.3. Asia-Pacific market size and forecast, by application
7.4.4. Asia-Pacific market size and forecast, by location of testing
7.4.5. Asia-Pacific market size and forecast, by country

7.4.5.1. China

7.4.5.1.1. China market size and forecast, by type
7.4.5.1.2. China market size and forecast, by application
7.4.5.1.3. China market size and forecast, by location of testing

7.4.5.2. India

7.4.5.2.1. India market size and forecast, by type
7.4.5.2.2. India market size and forecast, by application
7.4.5.2.3. India market size and forecast, by location of testing

7.4.5.3. Australia

7.4.5.3.1. Australia market size and forecast, by type
7.4.5.3.2. Australia market size and forecast, by application
7.4.5.3.3. Australia market size and forecast, by location of testing

7.4.5.4. Japan

7.4.5.4.1. Japan market size and forecast, by type
7.4.5.4.2. Japan market size and forecast, by application
7.4.5.4.3. Japan market size and forecast, by location of testing

7.4.5.5. Rest of Asia-Pacific

7.4.5.5.1. Rest of Asia-Pacific market size and forecast, by type
7.4.5.5.2. Rest of Asia-Pacific market size and forecast, by application
7.4.5.5.3. Rest of Asia-Pacific market size and forecast, by location of testing

7.5. LAMEA

7.5.1. Key market trends and opportunities
7.5.2. LAMEA market size and forecast, by type
7.5.3. LAMEA market size and forecast, by application
7.5.4. LAMEA market size and forecast, by location of testing
7.5.5. LAMEA market size and forecast, by country

7.5.5.1. Latin America

7.5.5.1.1. Latin America market size and forecast, by type
7.5.5.1.2. Latin America market size and forecast, by application
7.5.5.1.3. Latin America market size and forecast, by location of testing

7.5.5.2. Middle East

7.5.5.2.1. Middle East market size and forecast, by type
7.5.5.2.2. Middle East market size and forecast, by application
7.5.5.2.3. Middle East market size and forecast, by location of testing

7.5.5.3. Africa

7.5.5.3.1. Africa market size and forecast, by type
7.5.5.3.2. Africa market size and forecast, by application
7.5.5.3.3. Africa market size and forecast, by location of testing

Section 8: COMPANY PROFILES

8.1. Abbott Laboratories

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. Becton, Dickinson and Company

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance

8.3. BioMerieux

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance

8.4. Bio-Rad Laboratories, Inc.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance

8.5. Danaher Corporation

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance

8.6. F. HOFFMANN-LA ROCHE LTD.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance

8.7. Siemens AG

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance

8.8. Thermo Fisher Scientific, Inc.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance

8.9. PerkinElmer Inc.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance

8.10. Tosoh Corporation

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Business performance